Small molecules have always been of interest in chemistry and biology because of their ability to exert powerful effects on the functions of macromolecules comprising living systems. Screening collections or libraries of small molecules is the most common way to identify new chemical modulators of protein function and constitutes one of the bases of medicinal chemistry. While a general consensus has emerged that library size is not decisive, the concept of library diversity, in terms of molecular structure and, more importantly, molecular function, has become crucial, making the efficient creation of functionally diverse small molecule collections a formidable challenge. When a specific biological target is chosen, the compounds considered in the screening process are usually selected or designed on the basis of knowledge of the target structure or mimicking the structure of known natural ligands. Their synthesis can be planned effectively with retrosynthetic analysis (Target-Oriented Synthesis, TOS). However, when the precise nature of the biological target is unknown, the structural features required in potentially interacting small molecules cannot be defined a priori, and a productive approach can be the synthesis and evaluation of molecular libraries that achieve wide coverage of chemical space (Diversity-Oriented Synthesis, DOS). Indeed, the overall aim of DOS is to generate collections of small molecules with a high degree of structural, and thus functional, diversity that interrogates large areas of biologically-intriguing chemical space simultaneously. Within these two general synthetic strategies, the research herein described is focused on the development of new molecular scaffolds, which, in some cases, proved to be promising lead compounds. Within different synthetic approaches, the high potential of the multicomponent reactions with unprecedented components has been exploited and, on the other hand, new protocols have been finely tuned to achieve new transformations. The synthesis of promising bioactive compounds and the creation of chemical libraries, mainly focused on boron-containing derivatives and oxindole-based molecular frameworks, have been successfully carried out.
OPENING NEW CHEMICAL SPACE IN DRUG DISCOVERY / M. Manenti ; tutor: A. Silvani ; coordinatore D. Roberto. Dipartimento di Chimica, 2024 Jan 29. 36. ciclo, Anno Accademico 2023.
OPENING NEW CHEMICAL SPACE IN DRUG DISCOVERY
M. Manenti
2024
Abstract
Small molecules have always been of interest in chemistry and biology because of their ability to exert powerful effects on the functions of macromolecules comprising living systems. Screening collections or libraries of small molecules is the most common way to identify new chemical modulators of protein function and constitutes one of the bases of medicinal chemistry. While a general consensus has emerged that library size is not decisive, the concept of library diversity, in terms of molecular structure and, more importantly, molecular function, has become crucial, making the efficient creation of functionally diverse small molecule collections a formidable challenge. When a specific biological target is chosen, the compounds considered in the screening process are usually selected or designed on the basis of knowledge of the target structure or mimicking the structure of known natural ligands. Their synthesis can be planned effectively with retrosynthetic analysis (Target-Oriented Synthesis, TOS). However, when the precise nature of the biological target is unknown, the structural features required in potentially interacting small molecules cannot be defined a priori, and a productive approach can be the synthesis and evaluation of molecular libraries that achieve wide coverage of chemical space (Diversity-Oriented Synthesis, DOS). Indeed, the overall aim of DOS is to generate collections of small molecules with a high degree of structural, and thus functional, diversity that interrogates large areas of biologically-intriguing chemical space simultaneously. Within these two general synthetic strategies, the research herein described is focused on the development of new molecular scaffolds, which, in some cases, proved to be promising lead compounds. Within different synthetic approaches, the high potential of the multicomponent reactions with unprecedented components has been exploited and, on the other hand, new protocols have been finely tuned to achieve new transformations. The synthesis of promising bioactive compounds and the creation of chemical libraries, mainly focused on boron-containing derivatives and oxindole-based molecular frameworks, have been successfully carried out.File | Dimensione | Formato | |
---|---|---|---|
phd_unimi_R13125.pdf
Open Access dal 18/07/2024
Descrizione: complete thesis
Tipologia:
Altro
Dimensione
6.14 MB
Formato
Adobe PDF
|
6.14 MB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.